The Complainant is a family-owned pharmaceutical group of companies with roots going back to 1885, when it was founded by Albert Boehringer in Ingelheim am Rhein. Today, the Complainant is a global research-driven pharmaceutical enterprise with around 53,500 employees. It is divided into two business areas: human pharma and animal health. In 2023, the Complainant achieved net sales of EUR25.6 billion.<\/p>\n
The Respondent registered the disputed domain names <Boehringer--LnGelHeim.com> and <Boehringer-IngelhSeim.com> on 28 May 2025. The disputed domain names are both inactive. MX servers are configured for the domain name <boehringer-ingelhseim.com>. <\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain names.<\/p>", "no_response_filed": "
The Complainant contends that the requirements of the Policy have been met and that the disputed domain names should be transferred to it.<\/p>\n
No administratively compliant Response has been filed.<\/p>", "rights": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain names are identical or confusingly similar to a trade mark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "
The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain names (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain names have been registered and are being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "
The Panel notes that the amended complaint relates to two disputed domain names registered by the same Respondent with the same registrar within minutes of each other on the same date. The disputed domain names both resolve to inactive pages. Paragraph 3(c) of the Rules permits that “[t]he complaint may relate to more than one domain name, provided that the domain names are registered by the same domain-name holder”, as is the case here. <\/p>\n
The Panel is satisfied that all other procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Gregor Kleinknecht LLM MCIArb" ], "date_of_panel_decision": "2025-06-29 00:00:00", "informal_english_translation": "
The Complainant owns several trade marks consisting of the name BOEHRINGER INGELHEIM, including the international trade mark BOEHRINGER-INGELHEIM, registration number 221544, first registered on 2 July 1959 in international classes 1, 2, 3, 4, 5, 6, 16, 17, 19, 29, 30 and 32; and the international trade mark BOEHRINGER INGELHEIM, registration number 568844, first registered on 22 March 1991 in international classes 1, 2, 3, 4, 5, 9, 10, 16, 30 and 31.<\/p>\n
Furthermore, the Complainant owns multiple domain names consisting of the words “BOEHRINGER INGELHEIM”, including <boehringer-ingelheim.com>, registered on 1 September 1995, which is connected to the Complainant’s official website through which it informs Internet users and customers about its products and services.<\/p>", "decision_domains": { "boehringer--lngelheim.com": "TRANSFERRED", "boehringer-ingelhseim.com": "TRANSFERRED" }, "panelist": null, "panellists_text": null }